Rating History for Aardvark Therapeutics Inc (AARD) by Morgan Stanley

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/15/2026 Michael E Ulz Downgrade Underweight
(Equalweight)
3.00
(7.00)
6.59
(4.26)
-35.36% Details